title: Use of IP chemotherapy in ovarian cancer: the critical questions.
authors: National Cancer Institute, Bethesda, Maryland, USA.
authors: Edward L
authors: EL
authors: Trimble
authors: Keiichi
authors: K
authors: Fujiwara
authors: Christian
authors: C
authors: Marth
authors: Jeffrey
authors: J
authors: Abrams
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D043823:Taxoids; D002945:Cisplatin